Acetazolamide and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are female, 60+ old, also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,179 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,008 drugs and 2,937 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 19 people (0.32%) have Skin blushing/flushing.

Could Acetazolamide cause Skin blushing/flushing?

Among these 19 people:

What is the gender of people who have Skin blushing/flushing when taking Acetazolamide? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Skin blushing/flushing when taking Acetazolamide? *

What are other drugs people take besides Acetazolamide? *

What are other side effects people have besides Skin blushing/flushing? *

Dizziness: 8 people, 42.11%
Nausea (feeling of having an urge to vomit): 6 people, 31.58%
Pain In Jaw: 6 people, 31.58%
Fatigue (feeling of tiredness): 6 people, 31.58%
Diarrhea: 5 people, 26.32%
Weakness: 5 people, 26.32%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 26.32%
Headache (pain in head): 5 people, 26.32%
Dyspnea (difficult or laboured breathing): 4 people, 21.05%
Oxygen Saturation Decreased: 4 people, 21.05%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 31.58%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 26.32%
Nausea (feeling of having an urge to vomit): 3 people, 15.79%
Nausea And Vomiting: 2 people, 10.53%
Oedema (fluid collection in tissue): 1 person, 5.26%
Insulinoma (tumour of the pancreas that is derived from beta cells and secretes insulin): 1 person, 5.26%
Infection: 1 person, 5.26%
Hypoglycemia (low blood sugar): 1 person, 5.26%
High Density Lipoprotein Decreased: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Acetazolamide (6,179 reports)

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,008 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,937 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.